Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intracellular concentration of Antiretrovirals (INCA STUDY).

Next Previous
Trial Profile

Intracellular concentration of Antiretrovirals (INCA STUDY).

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 29 Nov 2012

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atazanavir (Primary) ; Efavirenz (Primary) ; Ritonavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms INCA

    • Most Recent Events

    • 16 Mar 2012 Actual end date (27 May 2009) added as reported by European Clinical Trials Database.
    • 08 Mar 2012 Lipid and lipoprotein substudy results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
    • 19 Oct 2011 An analysis of whether the combination of TDF and ATV/r is associated with a different evolution of eGFR in comparison to TDF and EFV, when it is estimated by CKD-EPI creatinine or CKD-EPI cystatin C equations, has been published in JAIDS.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top